Entrada Therapeutics
Earnings Surprise
Analysts estimated TRDA earnings of $-1.17 per share this quarter (Q4). TRDA's actual earnings were $-0.94 per share.
TRDA EPS surprise of 19.86%Analysts estimated TRDA earnings of $-0.96 per share this quarter (Q3). TRDA's actual earnings were $-1.06 per share.
TRDA EPS surprise of -10.55%Analysts estimated TRDA earnings of $-0.86 per share this quarter (Q2). TRDA's actual earnings were $-1.04 per share.
TRDA EPS surprise of -20.30%Analysts estimated TRDA earnings of $-0.80 per share this quarter (Q1). TRDA's actual earnings were $-0.42 per share.
TRDA EPS surprise of 47.81%Analysts estimated TRDA earnings of $-0.68 per share this quarter (Q4). TRDA's actual earnings were $0.03 per share.
TRDA EPS surprise of 104.39%Analysts estimated TRDA earnings of $-0.74 per share this quarter (Q3). TRDA's actual earnings were $-0.35 per share.
TRDA EPS surprise of 52.87%Analysts estimated TRDA earnings of $0.15 per share this quarter (Q2). TRDA's actual earnings were $1.55 per share.
TRDA EPS surprise of 948.01%Analysts estimated TRDA earnings of $-0.61 per share this quarter (Q1). TRDA's actual earnings were $0.68 per share.
TRDA EPS surprise of 212.23%Analysts estimated TRDA earnings of $-0.17 per share this quarter (Q4). TRDA's actual earnings were $-0.29 per share.
TRDA EPS surprise of 69.19%Analysts estimated TRDA earnings of $-0.75 per share this quarter (Q3). TRDA's actual earnings were $1.02 per share.
TRDA EPS surprise of -235.91%